Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart diseaseWenxin Wang, Manli Hu, Hui Liu et al.|Cell Metabolism|2021Cited by 223
The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitisPeng Zhang, Hongliang Li, Ling‐Ping Zhao et al.|Nature Medicine|2017Cited by 187
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signallingYan‐Xiao Ji, Hongliang Li|Nature Communications|2016Cited by 182
Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic SteatohepatitisChongshu Jian, Hongliang Li, Haiping Wang et al.|Cell Metabolism|2020Cited by 172
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 DiabetesXu Cheng, Hongliang Li, Ye-Mao Liu et al.|Cell Metabolism|2020Cited by 167